Categorizing differences in postpartum hemorrhage management and associated clinical factors

Abstract Objective To examine whether there is variation in postpartum hemorrhage (PPH) management and whether differences are associated with patient‐level factors and delivery hospital. Methods This is a retrospective cohort study of patients delivered at ≥20 weeks of gestation at any of four hospitals within one Connecticut healthcare system, with evidence of PPH, and receipt of intervention from 2012 to 2023. Patients with placenta accreta spectrum disorders, obstetric anal sphincter injuries, or stillbirth were excluded. The primary dependent variable was type of PPH treatment administered and structured as a four‐level categorical variable: (1) usual care treatment including synthetic oxytocin infusion and uterine massage; (2) receipt of less aggressive medication treatment with uterotonics only; (3) receipt of more aggressive medication treatment with uterotonics only; and (4) any procedure with or without medication use. Although hysterectomy is considered a later‐stage procedure in the setting of PPH, patients undergoing hysterectomy were included in the procedure group because insufficient cases of hysterectomy did not allow separate grouping. Maternal sociodemographic, clinical and pregnancy factors, and delivery hospital site were compared across the four‐level PPH treatment categories. Bivariate analyses and crude and adjusted multinomial logistic regression analyses were performed. Results Of 110,690 delivery encounters, 10,829 (9.8%) had documented evidence of study‐defined PPH. Of these deliveries, 10,075 (93.0%) met eligibility criteria and were included in the analysis: 4941 (49.0%) received usual care treatment, 2982 (29.6%) received less aggressive medication use only, 1308 (13.0%) received more aggressive medication use only, and 844 (8.4%) underwent procedure(s) with or without medication use. There was a wide range in the number of medication types and doses received, as well as a wide spectrum of the number and types of procedures employed. Adjusted multinomial logistic regression analyses showed significant differences in patient‐level factors (e.g., maternal age, race and ethnicity, gestational age, placenta previa, hypertensive disorders, and in vitro fertilization [IVF]) and delivery hospital among different types of PPH management. Conclusion There is significant variation in the management of PPH, and differences are associated with patient‐level factors and delivery hospital type and region, which may be a proxy for clinical management and available resources.

Authors

Institutions

Publication Details

Journal
Pregnancy
Published
2026-10-07
DOI
https://doi.org/10.1002/pmf2.70483
Primary Topic
Maternal and fetal healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Categorizing differences in postpartum hemorrhage management and associated clinical factors

Danna Tortal, Kevin Dysart, Heather H. Burris, Moeun Son et al.
Pregnancy
Maternal and fetal healthcare
article

Categorizing differences in postpartum hemorrhage management and associated clinical factors

Danna Tortal, Kevin Dysart, Heather H. Burris, Moeun Son, Jennifer Culhane, Leyla Şahin, Lisbet Lundsberg, Robert Whetsel, Caitlin Partridge
article en

Abstract

Abstract Objective To examine whether there is variation in postpartum hemorrhage (PPH) management and whether differences are associated with patient‐level factors and delivery hospital. Methods This is a retrospective cohort study of patients delivered at ≥20 weeks of gestation at any of four hospitals within one Connecticut healthcare system, with evidence of PPH, and receipt of intervention from 2012 to 2023. Patients with placenta accreta spectrum disorders, obstetric anal sphincter injuries, or stillbirth were excluded. The primary dependent variable was type of PPH treatment administered and structured as a four‐level categorical variable: (1) usual care treatment including synthetic oxytocin infusion and uterine massage; (2) receipt of less aggressive medication treatment with uterotonics only; (3) receipt of more aggressive medication treatment with uterotonics only; and (4) any procedure with or without medication use. Although hysterectomy is considered a later‐stage procedure in the setting of PPH, patients undergoing hysterectomy were included in the procedure group because insufficient cases of hysterectomy did not allow separate grouping. Maternal sociodemographic, clinical and pregnancy factors, and delivery hospital site were compared across the four‐level PPH treatment categories. Bivariate analyses and crude and adjusted multinomial logistic regression analyses were performed. Results Of 110,690 delivery encounters, 10,829 (9.8%) had documented evidence of study‐defined PPH. Of these deliveries, 10,075 (93.0%) met eligibility criteria and were included in the analysis: 4941 (49.0%) received usual care treatment, 2982 (29.6%) received less aggressive medication use only, 1308 (13.0%) received more aggressive medication use only, and 844 (8.4%) underwent procedure(s) with or without medication use. There was a wide range in the number of medication types and doses received, as well as a wide spectrum of the number and types of procedures employed. Adjusted multinomial logistic regression analyses showed significant differences in patient‐level factors (e.g., maternal age, race and ethnicity, gestational age, placenta previa, hypertensive disorders, and in vitro fertilization [IVF]) and delivery hospital among different types of PPH management. Conclusion There is significant variation in the management of PPH, and differences are associated with patient‐level factors and delivery hospital type and region, which may be a proxy for clinical management and available resources.

PregnancyVol. 2(6)
United States Food and Drug Administration (US), Children's Hospital of Philadelphia (US), Yale University (US), Yale New Haven Health System (US), Weill Cornell Medicine (US), Leonard Davis Institute of Health Economics (US), University of Pennsylvania (US)
Openalex Percentile: Top 7%
Maternal and fetal healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.